Suppr超能文献

基于计算机的垂体腺瘤免疫全景分析。

In silico analysis of the immunological landscape of pituitary adenomas.

机构信息

Department of Neurological Surgery, Yale University School of Medicine, P.O. Box 208082, New Haven, CT, 06520-8082, USA.

Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA.

出版信息

J Neurooncol. 2020 May;147(3):595-598. doi: 10.1007/s11060-020-03476-x. Epub 2020 Mar 31.

Abstract

PURPOSE

Immunotherapy has gained traction in the treatment of solid tumors but the immunological landscape of pituitary adenomas is not well defined. We sought to investigate the immunological composition in pituitary adenomas using RNA deconvolution (CIBERSORTx) on an existing gene expression dataset for pituitary adenomas.

METHODS

We applied an established computational approach (CIBERSORTx) on 134 pituitary adenomas from a previously published gene expression dataset to infer the proportions of 22 subsets of immune cells. We investigated associations between each immune cell type and tumor subtype.

RESULTS

We found that the majority of infiltrating immune cells within pituitary adenomas were comprised of M2 macrophages followed by resting CD4 memory T cells and mast cells. Silent pituitary tumors have higher M2 macrophage fractions when compared to other subtypes. In contrast, Cushing pituitary tumors, both overt and subclinical cases, had higher CD8 T cells fractions than GH tumors, prolactinomas, hyperthyroid tumors, and silent tumors.

CONCLUSIONS

RNA deconvolution of the immune infiltrates of pituitary adenomas using CIBERSORTx suggests that most pituitary adenomas comprise of M2 macrophages, but each adenoma subtype has a unique immune landscape. This may have implications in targeting each adenoma subtype with different immunotherapies.

摘要

目的

免疫疗法在治疗实体瘤方面取得了进展,但垂体腺瘤的免疫学特征尚不清楚。我们试图利用现有的垂体腺瘤基因表达数据集,通过 RNA 去卷积(CIBERSORTx)来研究垂体腺瘤中的免疫组成。

方法

我们将一种已建立的计算方法(CIBERSORTx)应用于先前发表的基因表达数据集中的 134 例垂体腺瘤,以推断 22 种免疫细胞亚群的比例。我们研究了每种免疫细胞类型与肿瘤亚型之间的关联。

结果

我们发现,垂体腺瘤中浸润的大多数免疫细胞是 M2 巨噬细胞,其次是静止的 CD4 记忆 T 细胞和肥大细胞。与其他亚型相比,无功能性垂体瘤的 M2 巨噬细胞比例更高。相比之下,库欣氏垂体瘤(显性和亚临床病例)的 CD8 T 细胞比例高于 GH 瘤、泌乳素瘤、甲状腺功能亢进瘤和无功能性肿瘤。

结论

使用 CIBERSORTx 对垂体腺瘤免疫浸润进行 RNA 去卷积表明,大多数垂体腺瘤由 M2 巨噬细胞组成,但每种腺瘤亚型都有独特的免疫景观。这可能对针对每种腺瘤亚型的不同免疫疗法具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36c8/7261241/f13442939408/nihms-1586569-f0001.jpg

相似文献

1
In silico analysis of the immunological landscape of pituitary adenomas.基于计算机的垂体腺瘤免疫全景分析。
J Neurooncol. 2020 May;147(3):595-598. doi: 10.1007/s11060-020-03476-x. Epub 2020 Mar 31.
5
The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas.免疫治疗在难治性垂体腺瘤和垂体癌中的进展。
Front Endocrinol (Lausanne). 2020 Dec 11;11:608422. doi: 10.3389/fendo.2020.608422. eCollection 2020.
8
Tumor-Associated Macrophages: New Horizons for Pituitary Adenoma Researches.肿瘤相关巨噬细胞:垂体腺瘤研究的新视野。
Front Endocrinol (Lausanne). 2021 Dec 2;12:785050. doi: 10.3389/fendo.2021.785050. eCollection 2021.

引用本文的文献

2
New insights in cellular senescence: The pituitary model.细胞衰老的新见解:垂体模型。
J Neuroendocrinol. 2025 May;37(5):e70008. doi: 10.1111/jne.70008. Epub 2025 Mar 3.
10
Recent Therapeutic Advances in Pituitary Carcinoma.垂体癌的近期治疗进展
J Immunother Precis Oncol. 2022 Dec 13;6(2):74-83. doi: 10.36401/JIPO-22-25. eCollection 2023 May.

本文引用的文献

2
Pangenomic Classification of Pituitary Neuroendocrine Tumors.基于泛基因组的垂体神经内分泌肿瘤分类。
Cancer Cell. 2020 Jan 13;37(1):123-134.e5. doi: 10.1016/j.ccell.2019.11.002. Epub 2019 Dec 26.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验